Islamabad, February 10, 2015 (PPI-OT): The delegation of M/s. Novartis Pharma (Pakistan) Limited had a meeting with Dr. Miftah Ismail, MOS/Chairman, BOI to further explore possibilities and strengthening the existing cooperation by the new initiatives and discussed the latest policy developments, which effect overall investment climate in Pakistan. M/s. Novartis is a world leader in the research and development of products to protect and improve health and well-being.
The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health. M/s. Novartis employs nearly 115,000 people in over 140 countries worldwide to help save lives and improve the quality of life. The Group is present in Pakistan through Novartis Pakistan Limited and is ranked as third largest multinational company in pharmaceutical sector and included in top 100 taxpayers of Pakistan.
The company has employees over 1500 associates in Pakistan with overall investment grown to PKR 6 billion in the field of patient access programs. The MOS/Chairman, Board of Investment, Dr. Miftah Ismail highlighted them the investment policy and informed them that the Board of Investment is mandated to promote FDI and provide facilitation to foreign / local investors and provide one window facilitation etc.
Dr. Miftah, appreciated the delegation in making investment in all sector of the economy including pharmaceutical and at the end MOS/Chairman, BOI assured fullest support of Board of Investment as and when needed, and also to provide a Conducive environment to all countries and provide low priced medicine to the masses of Pakistan.
For more information, contact:
Haji Ahmed Malik
Principal Information Officer
Press Information Department (PID)
Tel: +92-51-9252323 and +92-51-9252324
Fax: +92-51-9252325 and +92-51-9252326